September 9, 2020
End of Brexit transition period – what now for medicines and medical devices?
To this end the Medicines and Healthcare products Regulatory Agency (MHRA) has produced a set of guidance notes, which explain the rules in relation to:
- Clinical Trials
- Devices
- Licensing
- Importing and exporting
- IT systems
- Pharmacovigilance and
- Paediatrics
The rules are quite complex and businesses this sector should consider how the end of the transition period may affect them and plan for the effects. The guidance can be found here.
Share on: